Neuropathological Mechanisms of Seizures in Autism Spectrum Disorder
Open accessThe DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
This manuscript reviews biological abnormalities shared by autism spectrum disorder (ASD) and epilepsy. Two neuropathological findings are shared by ASD and epilepsy: abnormalities in minicolumn architecture and γ-aminobutyric acid (GABA) neurotransmission. The peripheral neuropil, which is the region that contains the inhibition circuits of the minicolumns, has been found to be decreased in the post-mortem ASD brain. ASD and epilepsy are associated with inhibitory GABA neurotransmission abnormalities including reduced GABAA and GABAB subunit expression. These abnormalities can elevate the excitation-to-inhibition balance, resulting in hyperexcitablity of the cortex and, in turn, increase the risk of seizures. Medical abnormalities associated with both epilepsy and ASD are discussed. These include specific genetic syndromes, specific metabolic disorders including disorders of energy metabolism and GABA and glutamate neurotransmission, mineral and vitamin deficiencies, heavy metal exposures and immune dysfunction. Many of these medical abnormalities can result in an elevation of the excitatory-to-inhibitory balance. Fragile X is linked to dysfunction of the mGluR5 receptor and Fragile X, Angelman and Rett syndromes are linked to a reduction in GABAA receptor expression. Defects in energy metabolism can reduce GABA interneuron function. Both pyridoxine dependent seizures and succinic semialdehyde dehydrogenase deficiency cause GABA deficiencies while urea cycle defects and phenylketonuria cause abnormalities in glutamate neurotransmission. Mineral deficiencies can cause glutamate and GABA neurotransmission abnormalities and heavy metals can cause mitochondrial dysfunction which disrupts GABA metabolism. Thus, both ASD and epilepsy are associated with similar abnormalities that may alter the excitatory-to-inhibitory balance of the cortex. These parallels may explain the high prevalence of epilepsy in ASD and the elevated prevalence of ASD features in individuals with epilepsy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Model of autism: increased ratio of excitation/inhibition in key neural systems
Rubenstein, J. L. R., & Merzenich, M. M. (2003) · Genes, Brain and Behavior · doi:10.1034/j.1601-183x.2003.00037.x · Cited by 2,768
Neuroglial activation and neuroinflammation in the brain of patients with autism
Vargas, D. L., Nascimbene, C., Krishnan, C., Zimmerman, A. W., & Pardo, C. A. (2005) · Annals of Neurology · doi:10.1002/ana.20315 · Cited by 2,149 · cited 3×
“Unusually high levels of proinflammatory cytokines have been found in the cerebrospinal fluid of individuals with ASD (Vargas et al., 2005).”
BackgroundInfluentialMacDermott, A. B., Mayer, M. L., Westbrook, G. L., Smith, S. J., & Barker, J. L. (1986) · Nature · doi:10.1038/321519a0 · Cited by 1,835
The importance of dendritic mitochondria in the morphogenesis and plasticity of spines and synapses
Li, Z., Okamoto, K.-I., Hayashi, Y., & Sheng, M. (2004) · Cell · doi:10.1016/j.cell.2004.11.003 · Cited by 1,498 · cited 2×
“A reduction of GABAergic inhibitory activity has been proposed to result in hyperexcitability of minicolumn circuits and can explain some of the symptomatology observed in ASD, including the high incidence of seizures and auditory-tactile hypersensitivity (Rubenstein and Merzenich, 2003).”
BackgroundPeñagarikano, O., Abrahams, B. S., Herman, E. I., Winden, K. D., Gdalyahu, A., Dong, H., Sonnenblick, L. I., Gruver, R., Almajano, J., Bragin, A., et al. (2011) · Cell · doi:10.1016/j.cell.2011.08.040 · Cited by 1,075
A Neuroligin-3 Mutation Implicated in Autism Increases Inhibitory Synaptic Transmission in Mice
Tabuchi, K., Blundell, J., Etherton, M. R., Hammer, R. E., Liu, X., Powell, C. M., & Südhof, T. C. (2007) · Science · doi:10.1126/science.1146221 · Cited by 997
Schaefer, G. B., & Mendelsohn, N. J. (2013) · Genetics in Medicine · doi:10.1038/gim.2013.32 · Cited by 537
Synaptic dysfunction and abnormal behaviors in mice lacking major isoforms of Shank3
Wang, X., McCoy, P. A., Rodriguiz, R. M., Pan, Y., Je, H. S., Roberts, A. C., Kim, C. J., Berrios, J., Colvin, J. S., Bousquet-Moore, D., et al. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr212 · Cited by 537
SHANK3 and IGF1 restore synaptic deficits in neurons from 22q13 deletion syndrome patients
Shcheglovitov, A., Shcheglovitova, O., Yazawa, M., Portmann, T., Shu, R., Sebastiano, V., Krawisz, A., Froehlich, W., Bernstein, J. A., Hallmayer, J. F., et al. (2013) · Nature · doi:10.1038/nature12618 · Cited by 470
Mitochondrial dysfunction in autism
Giulivi, C., Zhang, Y.-F., Omanska-Klusek, A., Ross-Inta, C., Wong, S., Hertz-Picciotto, I., Tassone, F., & Pessah, I. N. (2010) · JAMA · doi:10.1001/jama.2010.1706 · Cited by 466
Clinical trials of N-acetylcysteine in psychiatry and neurology: A systematic review
Deepmala, Slattery, J., Kumar, N., Delhey, L., Berk, M., Dean, O., Spielholz, C., & Frye, R. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.04.015 · Cited by 463
Self-citationEnvironmental toxicants and autism spectrum disorders: a systematic review
Rossignol, D. A., Genuis, S. J., & Frye, R. E. (2014) · Translational Psychiatry · doi:10.1038/tp.2014.4 · Cited by 458
Self-citationVOLKMAR, F. R., & NELSON, D. S. (1990) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199001000-00020 · Cited by 439 · cited 1×
“For example, epilepsy is more prevalent in ASD than in the typically developing children with a prevalence ranging from 5 to 38% (Deykin and Macmahon, 1979; Volkmar and Nelson, 1990; Tuchman and Rapin, 2002; Danielsson et al., 2005; Hara, 2007).”
BackgroundGABAA Receptor Downregulation in Brains of Subjects with Autism
Fatemi, S. H., Reutiman, T. J., Folsom, T. D., & Thuras, P. D. (2009) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-008-0646-7 · Cited by 439
Self-citationThe temporal binding deficit hypothesis of autism
BROCK, J., BROWN, C. C., BOUCHER, J., & RIPPON, G. (2002) · Development and Psychopathology · doi:10.1017/s0954579402002018 · Cited by 419
Clement, J. P., Aceti, M., Creson, T. K., Ozkan, E. D., Shi, Y., Reish, N. J., Almonte, A. G., Miller, B. H., Wiltgen, B. J., Miller, C. A., et al. (2012) · Cell · doi:10.1016/j.cell.2012.08.045 · Cited by 385 · cited 1×
“The SYNGAP1 haploinsufficiency animal model shows an increase in neuronal excitability and an increase in seizure susceptibility (Clement et al., 2012).”
BackgroundBlatt, G. J., Fitzgerald, C. M., Guptill, J. T., Booker, A. B., Kemper, T. L., & Bauman, M. L. (2001) · Journal of Autism and Developmental Disorders · doi:10.1023/a:1013238809666 · Cited by 322 · cited 1×
“Individuals with ASD have been shown to have abnormalities in GABAergic brain systems (Blatt et al., 2001; Dhossche et al., 2002; Fatemi, 2008), as well as a reduction in GABAA(Fatemi et al., 2009) and GABAB (Fatemi et al., 2009) receptor subunits in both the frontal and parietal cortices, as…”
BackgroundDisordered visual processing and oscillatory brain activity in autism and Williams syndrome
Grice, S. J., Spratling, M. W., Karmiloff-Smith, A., Halit, H., Csibra, G., de Haan, M., & Johnson, M. H. (2001) · Neuroreport · doi:10.1097/00001756-200108280-00021 · Cited by 322
Disordered connectivity in the autistic brain: Challenges for the ‘new psychophysiology’
Rippon, G., Brock, J., Brown, C., & Boucher, J. (2007) · International Journal of Psychophysiology · doi:10.1016/j.ijpsycho.2006.03.012 · Cited by 308 · cited 2×
“A deficit in binding and gamma oscillations has been proposed to explain many of the symptoms related to ASD (e.g., visuoperceptual defects, understanding and using context; Grice et al., 2001; Brock et al., 2002; Brown et al., 2005; Rippon et al., 2007; Tommerdahl et al., 2007).”
BackgroundAutism and epilepsy: A retrospective follow-up study
Hara, H. (2007) · Brain and Development · doi:10.1016/j.braindev.2006.12.012 · Cited by 242 · cited 2×
“…Zimmerman, UMass Medical School, USA *Correspondence: Richard E. Frye refrye@uams.edu Specialty section: This article was submitted to Child and Adolescent Psychiatry, a section of the journal Frontiers in Neuroscience Received: 18 March 2016 Accepted: 18 April 2016 Published: 10 May 2016 Citation:”
BackgroundDeFelipe, J., Hendry, S. H. C., Hashikawa, T., Molinari, M., & Jones, E. G. (1990) · Neuroscience · doi:10.1016/0306-4522(90)90097-n · Cited by 231 · cited 2×
“This inhibitory stream insulates the minicolumn core from the excitation from other surrounding minicolumns (Defelipe et al., 1990; Favorov and Kelly, 1994; Defelipe, 1999).”
BackgroundGene expression analysis exposes mitochondrial abnormalities in a mouse model of Rett syndrome
Kriaucionis, S., Paterson, A., Curtis, J., Guy, J., MacLeod, N., & Bird, A. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.01665-05 · Cited by 219
Shavelle, R. M., Strauss, D. J., & Pickett, J. (2001) · Journal of Autism and Developmental Disorders · doi:10.1023/a:1013247011483 · Cited by 211
Cntnap4 differentially contributes to GABAergic and dopaminergic synaptic transmission
Karayannis, T., Au, E., Patel, J. C., Kruglikov, I., Markx, S., Delorme, R., Héron, D., Salomon, D., Glessner, J., Restituito, S., et al. (2014) · Nature · doi:10.1038/nature13248 · Cited by 183 · cited 1×
“Mutations in CNTNAP2 (Peñagarikano et al., 2011) or CNTNAP4 (Karayannis et al., 2014) result in reduced GABAergic neurotransmission.”
BackgroundRose, S., Frye, R. E., Slattery, J., Wynne, R., Tippett, M., Pavliv, O., Melnyk, S., & James, S. J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0085436 · Cited by 168
Self-citationGamma abnormalities during perception of illusory figures in autism
Brown, C., Gruber, T., Boucher, J., Rippon, G., & Brock, J. (2005) · Cortex · doi:10.1016/s0010-9452(08)70273-9 · Cited by 166 · cited 1×
“A deficit in binding and gamma oscillations has been proposed to explain many of the symptoms related to ASD (e.g., visuoperceptual defects, understanding and using context; Grice et al., 2001; Brock et al., 2002; Brown et al., 2005; Rippon et al., 2007; Tommerdahl et al., 2007).”
BackgroundFrye, R. E. (2015) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2014.08.134 · Cited by 117
Self-citationDisorders of creatine transport and metabolism
Longo, N., Ardon, O., Vanzo, R., Schwartz, E., & Pasquali, M. (2011) · American Journal of Medical Genetics Part C Seminars in Medical Genetics · doi:10.1002/ajmg.c.30292 · Cited by 101
Su, H., Fan, W., Coskun, P. E., Vesa, J., Gold, J.-A., Jiang, Y.-H., Potluri, P., Procaccio, V., Acab, A., Weiss, J. H., et al. (2011) · Neuroscience Letters · doi:10.1016/j.neulet.2009.06.079 · Cited by 80
Cited by
Neurobiological bases of autism–epilepsy comorbidity: a focus on excitation/inhibition imbalance
Bozzi, Y., Provenzano, G., & Casarosa, S. (2018) · European Journal of Neuroscience · doi:10.1111/ejn.13595 · Cited by 250
Neurobehavioral comorbidities of epilepsy: Role of inflammation
Mazarati, A. M., Lewis, M. L., & Pittman, Q. J. (2017) · Epilepsia · doi:10.1111/epi.13786 · Cited by 96
Epilepsy and autism severity: a study of 6,975 children
Ewen, J. B., Marvin, A. R., Law, K., & Lipkin, P. H. (2019) · Autism Research · doi:10.1002/aur.2132 · Cited by 56
Modeling dopamine dysfunction in autism spectrum disorder: from invertebrates to vertebrates
DiCarlo, G. E., & Wallace, M. T. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.12.017 · Cited by 39
Atypical auditory language processing in adolescents with autism spectrum disorder
Tanigawa, J., Kagitani-Shimono, K., Matsuzaki, J., Ogawa, R., Hanaie, R., Yamamoto, T., Tominaga, K., Nabatame, S., Mohri, I., Taniike, M., et al. (2018) · Clinical Neurophysiology · doi:10.1016/j.clinph.2018.05.014 · Cited by 17
Metadata
- Authors
- Frye, R. E., Casanova, M. F., Fatemi, S. H., Folsom, T. D., Reutiman, T. J., Brown, G. L., Edelson, S. M., Slattery, J. C., & Adams, J. B.
- Venue
- Frontiers in Neuroscience
- Publisher
- Frontiers Media SA
- Published
- 2016-05-10
- Volume
- 10
- Pages
- 192-192
- ISSN
- 1662-453X (ISSN-L)
- OpenAlex
- W2368499347
- Cited by
- 94
- References
- 29
- FWCI
- 8.28
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.